ALX Oncology Holdings Inc. Common Stock
Symbol: ALXO (NASDAQ)
1.05
▼ (-11.02%) -0.130
Company Description:
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Key Stats
- Today's Open: $1.18
- Today's High: $1.22
- Today's Low: $1.017
- Today's Volume: 411.43K
- Yesterday Close: $1.18
- Yesterday High: $1.27
- Yesterday Low: $1.18
- Yesterday Volume: 361.66K
- Last Min Volume: 573
- Last Min High: $1.05
- Last Min Low: $1.05
- Last Min VWAP: $1.05
Company Profile
- Name: ALX Oncology Holdings Inc. Common Stock
- Website: https://www.alxoncology.com
- Listed Date: 2020-07-17
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001810182
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $56.76M
- Round Lot: 100
- Outstanding Shares: 53.55M
- Asset Type: CS
RECENT FILINGS FOR ALXO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | 8-K | View |
| 2025-08-20 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 3 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-08 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-12 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-04-25 | 8-K | View |
| 2025-04-24 | EFFECT | View |
| 2025-04-23 | CORRESP | View |
| 2025-04-21 | ARS | View |
Latest News on ALXO